Inventor · disambiguated record
Fabrice Heitz
Also filed as: HEITZ FABRICE
4 granted patents·3 pending applications·3 citations·filing 2013–2022
65Inventor score
Files withNEURIMMUNE HOLDING AG7
Top patents by PatentIndex Score
7 records- 0178US10882902B2Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2018·Granted Jan 5, 2021·1 cites·16 claims
- 0271US10072074B2Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2016·Granted Sep 11, 2018·1 cites·26 claims
- 0369US9475866B2Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2013·Granted Oct 25, 2016·1 cites·22 claims
- 0469US2023287106A1Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose toleranceNEURIMMUNE HOLDING AG·Filed 2022·Application pending·0 cites
- 0567US2021107972A1Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2020·Application pending·0 cites
- 0660US2020231667A1Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose toleranceNEURIMMUNE HOLDING AG·Filed 2019·Application pending·0 cites
- 0752US10544213B2Compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose toleranceNEURIMMUNE HOLDING AG·Filed 2015·Granted Jan 28, 2020·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →